Daewoong Pharmaceutical Strengthens Industry-Academia Collaboration to Train Indonesian Master's and Doctoral Global Pharma-Bio Experts

'Daewoong Global DDS Education Program' 4th Cohort Launch Ceremony

[Asia Economy Reporter Lee Gwan-joo] Daewoong Pharmaceutical announced on the 6th that it held the launch ceremony for the 4th class of the 'Daewoong Global DDS Education Program' simultaneously online and offline.

The Daewoong Global DDS Education Program is a talent development program for master's and doctoral students that provides research practical experience and education with the aim of nurturing global leaders who will contribute to the Indonesian pharmaceutical bio industry.

The launch ceremony included an introduction to Daewoong Pharmaceutical's Indonesia business, congratulatory remarks from the Indonesian Ambassador to Korea, and the awarding of scholarship certificates. Gandhi Sulistiyanto, the Indonesian Ambassador to Korea, toured the Daewoong Pharmaceutical Bio Center with the DDS 4th class scholarship students and encouraged them.

This 4th class of the Daewoong Global DDS Education Program will be held for four months until December at the Daewoong Pharmaceutical R&D Center. The 11 participating scholarship students will have broad and specialized learning opportunities such as ▲formulation technology practice and new product development projects ▲1:1 mentoring with Daewoong Pharmaceutical researchers ▲expert lectures ▲pharmaceutical factory GMP practice. Especially from the 4th class, a professor from the Faculty of Pharmacy at the Indonesian National University will participate to conduct joint research, strengthening not only talent development but also an open collaboration platform to activate formulation and bio research.

Scholarship students who achieve excellent results will also be given opportunities to join Daewoong Pharmaceutical's research, quality, and production departments. In fact, nine students who passed the recruitment for Daewoong Pharmaceutical's R&D Center and global divisions among the graduates of the 1st and 2nd classes will start working in Korea from this month.

Jeon Seung-ho, CEO of Daewoong Pharmaceutical, said, "Professional talent development is essential for the nation's key industries to leap to the next stage," adding, "We hope that the global talents who grow through the Daewoong Global DDS Education Program will develop advanced pharmaceutical bio technologies that contribute to improving the quality of human life, and Daewoong Pharmaceutical will continue to expand research institutes and production facilities in Indonesia so that global talents can demonstrate their capabilities."

Daewoong Pharmaceutical continues to maintain a close cooperative relationship with Indonesia. Through its corporation and joint venture Daewoong Infion in Indonesia, it is conducting various open innovation projects such as biopharmaceutical business and global talent development projects.

This content was produced with the assistance of AI translation services.